These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31152622)

  • 1. MYCT1 represses apoptosis of laryngeal cancerous cells through the MAX/miR-181a/NPM1 pathway.
    Wang HT; Tong X; Zhang ZX; Sun YY; Yan W; Xu ZM; Fu WN
    FEBS J; 2019 Oct; 286(19):3892-3908. PubMed ID: 31152622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.
    Qu SY; Sun YY; Li YH; Xu ZM; Fu WN
    Cancer Med; 2017 Jun; 6(6):1389-1398. PubMed ID: 28485541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1/miR-629-3p/ESRP2 pathway.
    Yue PJ; Sun YY; Li YH; Xu ZM; Fu WN
    Cell Signal; 2020 Oct; 74():109709. PubMed ID: 32659265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
    Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
    BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma.
    Zhao X; Zhang W; Ji W
    Future Oncol; 2018 Jul; 14(17):1741-1753. PubMed ID: 29517349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and may participate in laryngeal carcinogenesis.
    Fu S; Guo Y; Chen H; Xu ZM; Qiu GB; Zhong M; Sun KL; Fu WN
    PLoS One; 2011; 6(10):e25648. PubMed ID: 21998677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
    Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
    Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1.
    Pu J; Wang J; Xu Z; Lu Y; Wu X; Wu Y; Shao Z; Tang Q; Wei H
    Hum Gene Ther Clin Dev; 2019 Jun; 30(2):67-73. PubMed ID: 30982352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway.
    Xu H; Zhu J; Hu C; Song H; Li Y
    J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-181a Targets PHLPP2 to Augment AKT Signaling and Regulate Proliferation and Apoptosis in Human Keloid Fibroblasts.
    Rang Z; Wang ZY; Pang QY; Wang YW; Yang G; Cui F
    Cell Physiol Biochem; 2016; 40(3-4):796-806. PubMed ID: 27915346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration.
    Zhang P; Guo Z; Hu R; He X; Jiao X; Zhu X
    Tumour Biol; 2015 Dec; 36(12):9693-701. PubMed ID: 26152285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression.
    Ting Y; Medina DJ; Strair RK; Schaar DG
    Biochem Biophys Res Commun; 2010 Apr; 394(3):606-11. PubMed ID: 20214878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal inhibition of miR-181a ameliorates 5-fluorouracil-induced mesangial cell apoptosis and nephrotoxicity.
    Liu XY; Zhang FR; Shang JY; Liu YY; Lv XF; Yuan JN; Zhang TT; Li K; Lin XC; Liu X; Lei Q; Fu XD; Zhou JG; Liang SJ
    Cell Death Dis; 2018 May; 9(6):610. PubMed ID: 29795190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.
    Zou C; Chen J; Chen K; Wang S; Cao Y; Zhang J; Sheng Y; Huang A; Tang H
    Exp Cell Res; 2015 Feb; 331(2):352-61. PubMed ID: 25449696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro-RNA-181a suppresses progestin-promoted breast cancer cell growth.
    Gu M; Wang L; Yang C; Li X; Jia C; Croteau S; Ruan X; Hardy P
    Maturitas; 2018 Aug; 114():60-66. PubMed ID: 29907248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.
    Ke G; Liang L; Yang JM; Huang X; Han D; Huang S; Zhao Y; Zha R; He X; Wu X
    Oncogene; 2013 Jun; 32(25):3019-27. PubMed ID: 22847611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.